JAKARTA, Indonesia, Nov. 25, 2025 /PRNewswire/ -- At 1:00 PM local time on November 24, 2025, Chery proudly launched the world's first…
Positive results from ianalumab pivotal Phase III trial in ITP patients previously treated with corticosteroids to be presented as late-breakerScemblix…
Sanofi and Regeneron’s Dupixent approved as the first targeted medicine in the EU in over a decade for chronic spontaneous…
24 November 2025 - Volleyball coach Lang Ping from China and wrestling coach Raúl de Jesús Trujillo Díaz from Cuba…
NEW YORK, Nov. 24, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from…
Company Announces Approximately $30 Million in Cash and Short-Term Investments Following Its October 27th Registered Direct Offering November 24, 2025…
NEW YORK, Nov. 20, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from…
November 21, 2025 16:30 ET | Source: Conavi Medical Corp. PRELIMINARY PROSPECTUS ACCESSIBLE ON SEDAR+ NOT FOR RELEASE OR DISTRIBUTION…
November 21, 2025 16:06 ET | Source: Supernus Pharmaceuticals, Inc. ROCKVILLE, Md., Nov. 21, 2025 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals,…
November 21, 2025 16:30 ET | Source: Teva Pharmaceutical Industries Ltd TEL AVIV, Israel, Nov. 21, 2025 (GLOBE NEWSWIRE) --…